Showing results (401-410 of 592) with videos related to
Sort By:
Pageof 60
Breast Cancer Research and Treatment|August 10, 2007
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancerValentina Guarneri, Antonio Frassoldati, Guido Ficarra, et al.Cancer Treatment Reviews|August 20, 2022
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, et al.Journal of Experimental & Clinical Cancer Research : CR|December 29, 2012
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinomaEleonora Brunello, Matteo Brunelli, Giuseppe Bogina, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2017
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant TreatmentSara Pilotto, Isabella Sperduti, Giovanni Leuzzi, et al.Current Oncology (Toronto, Ont.)|February 25, 2025
Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel MeetingFilippo de Marinis, Andrea Ardizzoni, Ilaria Attili, et al.Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.Oncotarget|April 24, 2015
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinomaEmilio Bria, Sara Pilotto, Eliana Amato, et al.Journal of Personalized Medicine|April 3, 2021
Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective AnalysisArmando Orlandi, Letizia Pontolillo, Caterina Mele, et al.Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2012
Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB studyValentina Guarneri, Antonio Frassoldati, Alberto Bottini, et al.Pageof 60